Keep up to date on our investments and business developments in recent news stories and summaries.

FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI

Aug 02, 2023 – FACIT and T-CAIREM announce partnership to commercialize medical artificial intelligence (AI) innovations. The partners intend to harness both T-CAIREM’s innovative translational research in AI and FACIT’s unique commercialization-venture model to build the next generation of Ontario biotechnology companies. The joint mission will accelerate the benefits of AI research to support patients battling cancer.

Read More

From Idea to Start up: FACIT President’s interview with Amanda Lang

May 01, 2023 – Watch FACIT President Dr. David O’Neill’s interview with Amanda Lang, host of Taking Stock on BNN Bloomberg. The episode, titled From Idea to Start up, originally aired on April 28, 2023. This was part of a special series about innovation in Canada and some of the challenges and opportunities.  FACIT was featured as a “success story” in the commercialization of intellectual property (IP) in Canada. Read More

Happy Holidays from the FACIT team!

Dec 05, 2022 – Your friends at FACIT wish you a healthy and relaxing holiday season. It has been a productive year and our team continues to grow the province’s biotech ecosystem through the commercialization of Ontario’s most promising cancer innovations. 

Read More

FACIT leads seed round in Nanology Labs

May 18, 2021 – FACIT deploys Ontario First capital, enables rising local start-up to reach critical value inflection point. FACIT has previously supported Nanology, spun out of the University of Toronto, through both its early-stage Prospects Oncology Fund and seed-stage Compass Rose Oncology Fund.

Read More

Healthcare Software Start-Up Ziliomics Financed by FACIT

Jun 27, 2018 – Derived from a leading oncology bio-computing group and leveraging insights from the world’s largest cancer genomics projects, Ziliomics develops web-based, modular software platforms that help physicians make actionable treatment decisions for patients living with cancer.

Read More

FACIT Features: OICR Launches CTIP Initiative

Dec 06, 2017 – The Clinical Therapeutics Innovation Pipeline (CTIP) will support the local translation of Ontario discoveries into therapies with the potential for improving the lives of patients with cancer. Ten projects were selected in this highly competitive funding round, and reflect the strength of the province’s collaborative network and drug discoveries.

Read More

FACIT Features: Turnstone and AbbVie Announce Collaboration

Oct 11, 2017 – Turnstone Biologics, a startup co-founded by FACIT, announced a research, option and license agreement with AbbVie Inc. for up to three of Turnstone’s next-gen oncolytic viral immunotherapies. This partnership deepens the Ontario roots established by FACIT and its co-founders, expanding the scale of innovative research and local career opportunities for scientists.

Read More

FACIT Announces Investment in Propellon Therapeutics

Mar 22, 2017 – Seed funding from FACIT enables Propellon to accelerate the nomination of a candidate drug and position the Company for financing and/or entering a strategic partnership for clinical trials in patients with haematological cancers.

Read More

FACIT Launches The Prospects Oncology Fund

Mar 21, 2017 – FACIT announces the launch of The Prospects Oncology Fund, designed to advance early-stage Ontario cancer discoveries by supporting the proof-of-concept studies needed to attract seed-stage investment.

Read More

Privacy Analytics Acquired by IMS Health

May 26, 2016 – The transaction combines Privacy Analytics’ leading edge expertise in health data anonymization and de-identification with IMS Health’s broad range of healthcare information, technology and services solutions.

Read More